IBD Clinical Trials

82 recruitingLast updated: July 17, 2026

There are 82 actively recruiting ibd clinical trials across 35 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3. Top locations include Cincinnati, Ohio, United States, Paris, France, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


IBD Trials at a Glance

82 actively recruiting trials for ibd are listed on ClinicalTrialsFinder across 6 cities in 35 countries. The largest study group is Not Applicable with 27 trials, with the heaviest enrollment activity in Cincinnati, Paris, and Boston. Lead sponsors running ibd studies include Changhai Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna, and Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa.

Browse ibd trials by phase

Treatments under study

About IBD Clinical Trials

Looking for clinical trials for IBD? There are currently 17 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new IBD trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about IBD clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 82 trials

Recruiting

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)+4 more
Connecticut Children's Medical Center120 enrolled1 locationNCT07224113
Recruiting
Phase 2

Study of DISC-0974-201 in Participants With IBD and Anemia

AnemiaInflammatory Bowel Disease (IBD)Inflammatory Bowel Disease (IBD); Anemia
Disc Medicine, Inc21 enrolled13 locationsNCT07368972
Recruiting

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)+1 more
TIDHI Innovation Inc.200 enrolled12 locationsNCT07245394
Recruiting

IBD Biomarker Discovery and Validation Platform

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Diseases (IBD)
Sixth Affiliated Hospital, Sun Yat-sen University6,000 enrolled2 locationsNCT07686406
Recruiting

Epidemiological Evaluation Of Chronic Kidney Disease In Pediatric Patients With Inflammatory Bowel Disease

Inflammatory Bowel Diseases (IBD)
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria600 enrolled1 locationNCT07670988
Recruiting
Not Applicable

Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA

Crohn DiseaseMalnutrition or Risk of MalnutritionIBD+1 more
Lionhealth Srl Società Benefit146 enrolled4 locationsNCT07433946
Recruiting

Comparison Diagnostic Tests for the Diagnosis of CYTOmegalovirus Organ Disease in Patients With intestinalBOweL Diseases

Cytomegalovirus (CMV)Inflammatory Bowel Disease (IBD)
IRCCS Azienda Ospedaliero-Universitaria di Bologna200 enrolled1 locationNCT06793124
Recruiting

Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease

IBD (Inflammatory Bowel Disease)Ulcerative Colitis (UC)Crohn Disease (CD)
Shmuel Kivity, MD40 enrolled1 locationNCT07644117
Recruiting
Not Applicable

AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis

ColitisUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
ENBIOSIS BIOTECHNOLOGIES162 enrolled1 locationNCT07619638
Recruiting
Phase 1

A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult

IBD (Inflammatory Bowel Disease)Ulcerative Colitis (UC)CD - Crohn's Disease+2 more
Benethera (Shaoxing) Biotechnology Co., Ltd.68 enrolled1 locationNCT07632573
Recruiting

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Indeterminate Colitis+1 more
University of North Carolina, Chapel Hill200 enrolled9 locationsNCT07237516
Recruiting

Preparing for Maternal GBS Vaccine Trials in Africa

Invasive Bacterial Diseases (IBD)Group B StreptococcusMaternal Immunization
Barcelona Institute for Global Health18,100 enrolled10 locationsNCT06833957
Recruiting

Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)

Chronic Kidney DiseaseInflamatory Bowel Disease (Crohn's and Ulcerative Colitis)IBD and Renal Involement
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji6,000 enrolled1 locationNCT07593352
Recruiting
Not Applicable

Pre-Packaged Low-Residue Diet Assisting Bowel Preparation in Patients With Inflammatory Bowel Disease

IBD (Inflammatory Bowel Disease)Colonoscopy bowel preparation
Changhai Hospital500 enrolled2 locationsNCT07165470
Recruiting
Not Applicable

Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease

ColonoscopyIBD (Inflammatory Bowel Disease)Colonoscopy bowel preparation
Changhai Hospital1,000 enrolled1 locationNCT07353853
Recruiting

Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients

ColonoscopyIBD (Inflammatory Bowel Disease)Colonoscopy bowel preparation
Changhai Hospital1,000 enrolled1 locationNCT07335705
Recruiting
Not Applicable

Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Diet

Inflammatory Bowel Disease (IBD)
University of Alberta40 enrolled1 locationNCT06683105
Recruiting

Impact of IBD Activity on Frailty in Patients Over 60 Years

IBD
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa153 enrolled34 locationsNCT06844318
Recruiting
Not Applicable

Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease

IBD (Inflammatory Bowel Disease)Crohn Disease (CD)
University of British Columbia140 enrolled1 locationNCT07314606
Recruiting

Immunological Characteristics of Preclinical IBD

Crohn DiseaseUlcerative ColitisIBD
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa450 enrolled25 locationsNCT05698745